The specific cleavage site (PLGLYL) we chose for MMP-2 and MMP-9 was a sequence described by Albright et al. 2005 [22], which has low cleavage/activation by non-tumor proteases, especially by neprilysin, a membrane metalloendopeptidase highly expressed throughout the body. Here, MMP9 is linked to neoplasm.